MMR II Vaccination

600.000 đ

The MMR II vaccine is designed to prevent three highly contagious respiratory diseases: measles, mumps and rubella. This vaccine originates from the United States and is developed by Merck & Co., Inc.

Applicable only at: 414-420 Cao Thang Street, Ward 12, District 10, Ho Chi Minh City.

Individuals who are 16 years old and above.
Adults who have never been vaccinated against measles, mumps and rubella.
Adults who have not completed the full primary vaccination series or are unsure of vaccination history.
Individuals traveling to or working in areas with outbreaks of measles, mumps and rubella.
Persons working in crowded environments with a high risk of infection, such as healthcare workers, teachers, industrial workers, etc.
Women planning to become pregnant.

Provide immunity against measles, mumps and rubella viruses in individuals who are unvaccinated or have incomplete immunity.
Prevent rubella infection in women prior to pregnancy, ensuring a healthy pregnancy.

Individuals with a history of allergy to any component of the vaccine, including gelatin.
Individuals with a history of anaphylactic reaction to neomycin.
Individuals with acute illnesses or respiratory tract infections.
Individuals with untreated active tuberculosis or those undergoing immunosuppressive therapy.
Individuals with blood disorders, leukemia, lymphatic malignancies, malignant neoplasms affecting the bone marrow or lymphatic system.
Patients with primary or secondary immunodeficiency, those under immunosuppressive treatment, AIDS patients, individuals showing clinical signs of immunodeficiency; conditions associated with hypo- or agammaglobulinemia.
Family history of congenital or hereditary immunodeficiency, unless proven to have an immune response to the vaccine.
Women planning to become pregnant within one month.
Pregnant women, who should use contraception for three months following vaccination.

Dose 1: Initial dose.
Dose 2: 4 weeks after dose 1.

Provide comprehensive information about your medical history, current medications, and allergic reaction history.
Provide a vaccination history and any adverse reactions related to previous MMR II vaccinations.
Do not simultaneously administer immune globulin (IG) or other blood products with MMR II.
Be cautious before vaccination in the following cases: personal or family history of febrile seizures; severe allergy to eggs; history of thrombocytopenia.
Pay attention to post-vaccination reactions such as fever, rash and injection site reactions including pain, redness, swelling.
Pay attention to potential post-vaccination reactions reported in clinical trials, including headache, dizziness, febrile seizures, anaphylaxis or anaphylactoid reactions, arthritis, thrombocytopenia, encephalitis, encephalopathy.